PACIRA PHARMACEUTICALS INC

NASDAQ: PCRX
$48.49
-$1.53 (-3.1%)
Closing price February 21, 2020

Top Analyst Upgrades and Downgrades: Apple, Centene, Comcast, EA, Facebook, Intel, PG&E, P&G, SLM, Take-Two, Travelers and More

Stocks met some mixed and selective profit-taking in recent days, but the S&P 500 and Nasdaq managed to close slightly higher while the Dow Jones industrials did not. All three ...
Read Full Story »

20 Biopharma Stocks for Huge Upside Potential in 2020

Now that 2020 is well underway, investors are already moving on from just thinking about how wonderful the stock market performance was in 2019 and how wonderful stocks have been ...
Read Full Story »

11 Biotech and Pharma Stocks With Huge Upside Targets for 2020

After a solid 2019 has seen mixed trading in 2020, and after a massive run over the last decade, many investors are still trying to decide where and how they ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Applied Materials, Barrick Gold, Comcast, GoDaddy, Intel, PG&E, Qualcomm, Sirius XM and More

Stocks were indicated to open lower by a tiny margin on Monday, after the indications were for a positive open earlier in the morning. Investors have had less success buying ...
Read Full Story »

Why Analysts See Pacira Pharma in a Night and Day Contrast

Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) has found itself in the middle of a great opportunity but not being able to make the last mile of the race. Unfortunately, pain management ...
Read Full Story »

Major Biopharma Catalysts, Conferences and Decisions to Watch For in April

Companies in the biotech and pharmaceutical industries are subject to a sizable amount of risk with regards to their drug candidates passing clinical trials and gaining regulatory approval. But with ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Allergan, Autodesk, Home Depot, Marvell, Qualcomm, UnitedHealth, Walmart and More

Stocks screamed higher to all-time records on Tuesday, and the indexes were indicated higher on Wednesday as well. With the markets remaining right at all-time highs, it is important to ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Biogen, Cabot Oil & Gas, CenturyLink, NetApp, Square, T-Mobile, Wix.com and More

After a week of stocks seeming to look for a direction, while still bumping up against all-time highs, the major stock indexes were all indicated handily lower on Thursday morning. ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Barrick Gold, Buffalo Wild Wings, Caterpillar, Coca-Cola, GrubHub, Nabors Industries, Wynn Resorts and More

Stocks pulled back off of all-time highs this week, but the European Central Bank has announced that it plans to cut its €60 billion worth of bond buying in half, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Applied Materials, Baker Hughes, Blue Apron, Deere, Foot Locker, Lululemon, Nike, Plains All American, Total and Many More

Stocks were indicated to open marginally lower on Monday ahead of the Great American Eclipse, but investors need to keep in mind that the markets are still very close to ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Adobe, ClubCorp, Oracle, Silver Wheaton, Weatherford, Yahoo and Many More

Stocks were indicated marginally lower on Thursday morning but shares were off of their lows. Three major banks reported earnings that were generally deemed positive, but this is likely a ...
Read Full Story »

Red-Hot Biotech Companies Highlight Jefferies Top Stocks to Buy

Despite the incredible market rally since the election of Donald Trump, not all sectors have responded with the same gusto. One that has lagged some is biotech, and while the ...
Read Full Story »

Wedbush Has 3 Biotech Stocks to Buy With Massive Upside Potential

Needless to say, the biotech world has had a very difficult 18 months. Even the biggest and the best companies, many of which trade cheaper than big pharmaceutical companies, have ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Activision Blizzard, Anheuser-Busch, Amphenol, Biogen, Goldman Sachs BDC, Pure Storage and More

Once again, stocks across all the major indexes closed at record highs yesterday, on the back of what many perceived as a very strong speech from President Trump to a ...
Read Full Story »

4 Biopharma Stocks Moving the Market on Wednesday

Markets have hit new intraday highs on Wednesday, continuing to climb in the wake of the White House announcements. Although the health care sector has been attacked by the U.S. ...
Read Full Story »